Advertisement
U.S. markets closed

Calliditas Therapeutics AB (publ) (CALT)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
22.05-0.41 (-1.83%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close22.46
Open21.40
Bid22.10 x 1000
Ask24.00 x 800
Day's Range21.09 - 22.10
52 Week Range15.25 - 29.30
Volume10,435
Avg. Volume15,215
Market Cap591.734M
Beta (5Y Monthly)1.39
PE Ratio (TTM)N/A
EPS (TTM)-1.70
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est41.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CALT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Calliditas Therapeutics AB
    Daily – Vickers Top Insider Picks for 03/01/2024The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    18 days agoArgus Research
View more